Annual Working Capital
$400.57 M
+$101.48 M+33.93%
31 December 2023
Summary:
Celldex Therapeutics annual working capital is currently $400.57 million, with the most recent change of +$101.48 million (+33.93%) on 31 December 2023. During the last 3 years, it has risen by +$216.93 million (+118.13%). CLDX annual working capital is now at all-time high.CLDX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$746.75 M
-$37.57 M-4.79%
01 September 2024
Summary:
Celldex Therapeutics quarterly working capital is currently $746.75 million, with the most recent change of -$37.57 million (-4.79%) on 01 September 2024. Over the past year, it has increased by +$528.65 million (+242.39%). CLDX quarterly working capital is now -7.70% below its all-time high of $809.03 million, reached on 31 March 2024.CLDX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.9% | +242.4% |
| 3 y3 years | +118.1% | +81.1% |
| 5 y5 years | +363.2% | +1081.3% |
CLDX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +118.1% | -7.7% | +242.4% |
| 5 y | 5 years | at high | +627.6% | -7.7% | +1560.0% |
| alltime | all time | at high | +9125.7% | -7.7% | >+9999.0% |
Celldex Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $746.75 M(-4.8%) |
| June 2024 | - | $784.32 M(-3.1%) |
| Mar 2024 | - | $809.03 M(+102.0%) |
| Dec 2023 | $400.57 M(+33.9%) | $400.57 M(+83.7%) |
| Sept 2023 | - | $218.10 M(-12.5%) |
| June 2023 | - | $249.17 M(-9.2%) |
| Mar 2023 | - | $274.38 M(-8.3%) |
| Dec 2022 | $299.08 M(-24.2%) | $299.08 M(-6.0%) |
| Sept 2022 | - | $318.31 M(-5.8%) |
| June 2022 | - | $338.03 M(-10.1%) |
| Mar 2022 | - | $376.14 M(-4.6%) |
| Dec 2021 | $394.31 M(+114.7%) | $394.31 M(-4.4%) |
| Sept 2021 | - | $412.38 M(+169.3%) |
| June 2021 | - | $153.12 M(-6.9%) |
| Mar 2021 | - | $164.52 M(-10.4%) |
| Dec 2020 | $183.64 M(+233.6%) | $183.64 M(-3.7%) |
| Sept 2020 | - | $190.72 M(-3.7%) |
| June 2020 | - | $198.15 M(+340.5%) |
| Mar 2020 | - | $44.99 M(-18.3%) |
| Dec 2019 | $55.05 M(-36.3%) | $55.05 M(-12.9%) |
| Sept 2019 | - | $63.22 M(-13.2%) |
| June 2019 | - | $72.86 M(-5.2%) |
| Mar 2019 | - | $76.86 M(-11.1%) |
| Dec 2018 | $86.48 M(-26.1%) | $86.48 M(-8.1%) |
| Sept 2018 | - | $94.12 M(-6.2%) |
| June 2018 | - | $100.30 M(-6.2%) |
| Mar 2018 | - | $106.96 M(-8.6%) |
| Dec 2017 | $117.02 M(-27.0%) | $117.02 M(-4.4%) |
| Sept 2017 | - | $122.40 M(-6.8%) |
| June 2017 | - | $131.26 M(-10.4%) |
| Mar 2017 | - | $146.44 M(-8.7%) |
| Dec 2016 | $160.35 M(-39.4%) | $160.35 M(-16.1%) |
| Sept 2016 | - | $191.08 M(-8.5%) |
| June 2016 | - | $208.78 M(-11.4%) |
| Mar 2016 | - | $235.65 M(-11.0%) |
| Dec 2015 | $264.70 M(+46.7%) | $264.70 M(-7.3%) |
| Sept 2015 | - | $285.62 M(-8.7%) |
| June 2015 | - | $312.85 M(-8.8%) |
| Mar 2015 | - | $342.98 M(+90.0%) |
| Dec 2014 | $180.49 M(-36.6%) | $180.49 M(-13.3%) |
| Sept 2014 | - | $208.21 M(-11.2%) |
| June 2014 | - | $234.40 M(-8.9%) |
| Mar 2014 | - | $257.31 M(-9.7%) |
| Dec 2013 | $284.84 M(+322.4%) | $284.84 M(+131.3%) |
| Sept 2013 | - | $123.15 M(-14.4%) |
| June 2013 | - | $143.93 M(-13.4%) |
| Mar 2013 | - | $166.12 M(+146.4%) |
| Dec 2012 | $67.43 M(+67.0%) | $67.43 M(+5.9%) |
| Sept 2012 | - | $63.68 M(-6.1%) |
| June 2012 | - | $67.82 M(-17.0%) |
| Mar 2012 | - | $81.69 M(+102.3%) |
| Dec 2011 | $40.39 M(-5.5%) | $40.39 M(-24.7%) |
| Sept 2011 | - | $53.60 M(-14.8%) |
| June 2011 | - | $62.88 M(+68.5%) |
| Mar 2011 | - | $37.31 M(-12.7%) |
| Dec 2010 | $42.74 M(-38.6%) | $42.74 M(+19.0%) |
| Sept 2010 | - | $35.92 M(-19.4%) |
| June 2010 | - | $44.54 M(-16.7%) |
| Mar 2010 | - | $53.46 M(-23.2%) |
| Dec 2009 | $69.57 M(+111.0%) | $69.57 M(+400.4%) |
| Sept 2009 | - | $13.90 M(-32.7%) |
| June 2009 | - | $20.65 M(-25.7%) |
| Mar 2009 | - | $27.79 M(-15.7%) |
| Dec 2008 | $32.98 M(-843.0%) | $32.98 M(-11.2%) |
| Sept 2008 | - | $37.14 M(-24.0%) |
| June 2008 | - | $48.87 M(+336.4%) |
| Mar 2008 | - | $11.20 M(-352.3%) |
| Dec 2007 | -$4.44 M(-113.7%) | -$4.44 M(-135.2%) |
| Sept 2007 | - | $12.62 M(-33.1%) |
| June 2007 | - | $18.86 M(-20.5%) |
| Mar 2007 | - | $23.72 M(-26.6%) |
| Dec 2006 | $32.32 M | $32.32 M(-19.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $39.93 M(-17.5%) |
| June 2006 | - | $48.40 M(-11.6%) |
| Mar 2006 | - | $54.74 M(+161.7%) |
| Dec 2005 | $20.91 M(-28.5%) | $20.91 M(-16.4%) |
| Sept 2005 | - | $25.01 M(-15.3%) |
| June 2005 | - | $29.51 M(+21.5%) |
| Mar 2005 | - | $24.30 M(-16.9%) |
| Dec 2004 | $29.25 M(+54.6%) | $29.25 M(-10.8%) |
| Sept 2004 | - | $32.80 M(-11.0%) |
| June 2004 | - | $36.87 M(-9.0%) |
| Mar 2004 | - | $40.50 M(+114.0%) |
| Dec 2003 | $18.92 M(-15.6%) | $18.92 M(-12.5%) |
| Sept 2003 | - | $21.62 M(+52.5%) |
| June 2003 | - | $14.17 M(-17.3%) |
| Mar 2003 | - | $17.13 M(-23.6%) |
| Dec 2002 | $22.43 M(-40.7%) | $22.43 M(-12.1%) |
| Sept 2002 | - | $25.52 M(-6.7%) |
| June 2002 | - | $27.36 M(-16.4%) |
| Mar 2002 | - | $32.74 M(-13.4%) |
| Dec 2001 | $37.82 M(-18.5%) | $37.82 M(+22.2%) |
| Sept 2001 | - | $30.95 M(-16.9%) |
| June 2001 | - | $37.24 M(-13.0%) |
| Mar 2001 | - | $42.79 M(-7.8%) |
| Dec 2000 | $46.41 M(+277.6%) | $46.41 M(-0.1%) |
| Sept 2000 | - | $46.47 M(+210.5%) |
| June 2000 | - | $14.97 M(-13.9%) |
| Mar 2000 | - | $17.39 M(+41.5%) |
| Dec 1999 | $12.29 M(-0.1%) | $12.29 M(-21.2%) |
| Sept 1999 | - | $15.60 M(+102.6%) |
| June 1999 | - | $7.70 M(-20.6%) |
| Mar 1999 | - | $9.70 M(-21.1%) |
| Dec 1998 | $12.30 M(+167.4%) | $12.30 M(-8.9%) |
| Sept 1998 | - | $13.50 M(+181.3%) |
| June 1998 | - | $4.80 M(-30.4%) |
| Mar 1998 | - | $6.90 M(+50.0%) |
| Dec 1997 | $4.60 M(-60.7%) | $4.60 M(-31.3%) |
| Sept 1997 | - | $6.70 M(-30.2%) |
| June 1997 | - | $9.60 M(-14.3%) |
| Mar 1997 | - | $11.20 M(-4.3%) |
| Dec 1996 | $11.70 M(+4.5%) | $11.70 M(-16.4%) |
| Sept 1996 | - | $14.00 M(+133.3%) |
| June 1996 | - | $6.00 M(-27.7%) |
| Mar 1996 | - | $8.30 M(-25.9%) |
| Dec 1995 | $11.20 M(-25.8%) | $11.20 M(+89.8%) |
| Sept 1995 | - | $5.90 M(-40.4%) |
| June 1995 | - | $9.90 M(-22.0%) |
| Mar 1995 | - | $12.70 M(-15.9%) |
| Dec 1994 | $15.10 M(-42.1%) | $15.10 M(-12.7%) |
| Sept 1994 | - | $17.30 M(-13.9%) |
| June 1994 | - | $20.10 M(-14.5%) |
| Mar 1994 | - | $23.50 M(-10.0%) |
| Dec 1993 | $26.10 M(+55.4%) | $26.10 M(+143.9%) |
| Sept 1993 | - | $10.70 M(-18.9%) |
| June 1993 | - | $13.20 M(-12.0%) |
| Mar 1993 | - | $15.00 M(-17.6%) |
| Dec 1992 | $16.80 M(-19.2%) | - |
| Oct 1992 | - | $18.20 M(-7.1%) |
| July 1992 | - | $19.60 M(-5.8%) |
| Apr 1992 | - | $20.80 M(-7.6%) |
| Apr 1992 | $20.80 M(+166.7%) | - |
| Jan 1992 | - | $22.50 M(-2.2%) |
| Oct 1991 | - | $23.00 M(-5.3%) |
| July 1991 | - | $24.30 M(+211.5%) |
| Apr 1991 | $7.80 M(-23.5%) | $7.80 M(-1.3%) |
| Jan 1991 | - | $7.90 M(-9.2%) |
| Oct 1990 | - | $8.70 M(-6.5%) |
| July 1990 | - | $9.30 M(-8.8%) |
| Apr 1990 | $10.20 M(+24.4%) | $10.20 M(+39.7%) |
| Jan 1990 | - | $7.30 M(-11.0%) |
| Apr 1989 | $8.20 M(-20.4%) | $8.20 M(-20.4%) |
| Apr 1988 | $10.30 M(-16.3%) | $10.30 M(-16.3%) |
| Apr 1987 | $12.30 M(+434.8%) | $12.30 M(+434.8%) |
| Apr 1986 | $2.30 M | $2.30 M |
FAQ
- What is Celldex Therapeutics annual working capital?
- What is the all time high annual working capital for Celldex Therapeutics?
- What is Celldex Therapeutics annual working capital year-on-year change?
- What is Celldex Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly working capital year-on-year change?
What is Celldex Therapeutics annual working capital?
The current annual working capital of CLDX is $400.57 M
What is the all time high annual working capital for Celldex Therapeutics?
Celldex Therapeutics all-time high annual working capital is $400.57 M
What is Celldex Therapeutics annual working capital year-on-year change?
Over the past year, CLDX annual working capital has changed by +$101.48 M (+33.93%)
What is Celldex Therapeutics quarterly working capital?
The current quarterly working capital of CLDX is $746.75 M
What is the all time high quarterly working capital for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly working capital is $809.03 M
What is Celldex Therapeutics quarterly working capital year-on-year change?
Over the past year, CLDX quarterly working capital has changed by +$528.65 M (+242.39%)